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PROTEOMICS AS A TOOL FOR STUDYING OSTEOARTHRITIS
D. de Seny. GIGA Res., Univ. of Liège, CHU Liège, Liège, Belgium
Proteomics is the large-scale study of proteins expressed by cells,
tissues or organ. It describes the dynamics of cell regulation by
detecting molecular events related to the development of a disease. It is
a multidisciplinary approach using medical, biological, bioanalytical
and bioinformatics knowledge. One of the most promising applications
of proteomics studies is identiﬁcation of new biomarkers as indicators
of pathogenic processes or pharmacologic responses to a therapeutic
intervention. However, several practical considerations need to be
raised to set up a robust and sensitive strategy for biomarker discovery
in osteoarthritis (OA). OA is a heterogeneous, complex joint pathology.
Progression of OA is slow and periodic with intermittent episodes of
inﬂammatory ﬂares and remission periods. Therefore, biomarkers are
discontinuously released in biological ﬂuids.
This presentation will focus on current proteomic approaches and their
limitations in identifying the so-called soluble or “wet biomarkers”
measured in blood, serum, plasma, urine and synovial ﬂuid. The pres-
ence of a high quantity of proteins in such complex biological ﬂuid
make biomarkers discovery highly challenging. Nevertheless, current
approaches exist to extend accessible concentration range and deep
proteome detection. Comparison between a “targeted proteomic
approach” based in the evaluation of single disease-related molecule
levels and a “non-targeted proteomic approach” based on the simul-
taneous evaluation of hundreds proteins in a blind experiment using
gel-based methods or mass spectrometry will be reviewed. Based on
the assumption that a combination of biomarkers is more speciﬁc and
sensitive for disease diagnosis than single marker, non-targeted pro-
teomic technologies became highly attractive over the last decade.
However, the gap between biomarkers discovery and clinical imple-
mentation remains important, as only few biomarkers have already
been validated. All these practical considerations will be illustrated by
current proteomics studies.
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REHABILITATION FOR CARTILAGE DEFECT IN EARLY KNEE OA
M. Risberg. NAR, Dept. of Sport Med., Norwegian Sch. Sport Sci., Oslo,
Norway
Background: It is well established that treatment and rehabilitation of
patients with knee OA needs to start early in the disease process. Knee
injuries and obesity have shown to be two of the most signiﬁcant
predictors for onset and progression of knee OA largely mediated by
biomechanical forces acting across the knee. Articular cartilage in the
knee is prone to damage by trauma or degeneration and damaged
cartilage is one of the key issues in the OAdisease process. Focal cartilage
defects as well as other major knee injuries affect the mechanical envi-
ronment in the joint possibly through changes in knee articular cartilage
loading. The effect of exercise interventions for reducing symptoms and
improving function in patients with knee OA has been well established,
but the effect of exercise therapy for patients with focal cartilage defects
is spares. Cartilage loading has shown to be signiﬁcant for cartilage
health, however, we lack knowledge on how muscle function affect
cartilage health. Quadriceps muscle strength in particular has shown to
inﬂuence load transmission and absorption across the knee joint
Objective: The objective of this presentation is to go through the
evidence for the effect of exercises for patients with cartilage defect in
early knee OA. Furthermore, the aim is to present the Oslo CARE study
to highlight the need for speciﬁcally descried exercise therapy programs
and how this exercise therapy program have shown to inﬂuence
symptoms, disabilities and cartilage quality using quantitative MRI.
Methods: A narrative literature review will be presented as well as the
development of the exercise therapy program and the outcomes from
the Oslo CARE study. The Oslo CARE study included balance exercises,
balance with resistance, followed by traditionally resistance training
and ﬁnally plyometric exercises for patients with focal cartilage defects.
The exercises aimed at generating muscle strength and power impor-
tant for daily life and sport performance, without a potential deleterious
effect on cartilage health.Results: Clinically patients with focal cartilage defect experience pain,
effusion, muscle weakness and other neuromuscular deﬁcits.
Furthermore, there is a wide range of the type, size and location of the
patients’ focal cartilage defect that should inﬂuence the type of
exercises performed. It has been stated that conservative management
of patients with cartilage defect are inappropriate since they are likely
non-responders to such treatment. There are to our knowledge no
RCTs on the effect of exercise therapy for patients with focal cartilage
defects, but a few studies have examined the effect of exercises after
cartilage repair. Different theories have been proposed for why exer-
cises seem to work for patients with knee OA: neuromuscular, peri-
articular, intra-articular components, general ﬁtness/health, and
psychosocial. Studies seem to support that at least low to moderate
activities and exercises improve function and are not deleterious to
the knee articular cartilage. However, the mechanisms for why exer-
cises seem to affect the patients' symptoms or function are not well
understood. The Oslo CARE study showed that patients with focal
cartilage defects improved knee function over time, without delete-
rious on the knee articular cartilage.
Discussion: We need to increase our focus on why exercises seem to
work for patients with cartilage defects in early knee OA. We need to
move from the palliative treatment of symptoms and dysfunction to
a better understanding of how and if exercises affect the onset and
progression of the knee OA process. Better rehabilitation programs for
patients with focal cartilage defects, patients with signiﬁcant predictors
for development of knee OA, needs to be undertaken. Themuscles of the
lower extremity, particular the quadriceps, have shown to play an
important role in the management of patients with knee OA.
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ROLE OF COMPLEMENT AND INFLAMMATION IN OSTEOARTHRITIS
W. Robinson. VA Palo Alto Hlth. Care System, Palo Alto, CA, USA
Purpose: Although low-grade inﬂammatory responses are observed in
OA, their contribution to its pathogenesis is unclear. We are investi-
gating the role for the complement system and inﬂammation in the
pathogenesis of OA.
Methods: Proteomic studies were performed on OA synovial ﬂuids and
membranes. Murine models of OA were used to further investigate the
role of the complement system and other inﬂammatory mediators.
Results: Through proteomic analyses of synovial ﬂuids and membranes
from individuals with osteoarthritis, we ﬁnd that expression and acti-
vation of complement and other inﬂammatory mediators in human
osteoarthritic joints. Using mice genetically deﬁcient in C5, C6, or
CD59a, we show that complement, and speciﬁcally the membrane
attack complex (MAC)-mediated arm of complement, is critical to the
development of OA. Immunoﬂuorescent staining demonstrated that
MAC co-localized with matrix metalloprotease (MMP)-13 and with
activated extracellular signal-regulated kinase (ERK) around chon-
drocytes in human osteoarthritic cartilage.
Conclusions: Our ﬁndings indicate that dysregulation of complement
and activation of inﬂammatory pathways in synovial joints plays
a critical role in the pathogenesis of osteoarthritis.
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SYNDECAN-4: ENVIRONMENTAL SENSOR AND MATRIX REGULATOR
M.R. Morgan. Univ. of Manchester, Manchester, United Kingdom
Cell migration and microenvironment remodeling are essential for
tissue morphogenesis, homeostasis and repair, and for the pathogenesis
of inﬂammatory, neoplastic and degenerative musculoskeletal diseases.
Adhesion contacts are integrin-mediated complexes that integrate the
extracellular environment with the contractile machinery of the cell.
Precise spatial and temporal coordination of adhesion complex
dynamics is essential to permit efﬁcient cell migration and to regulate
extracellular matrix remodelling.
Differential engagement of a5b1 and aVb3 integrins regulates the
balance between adhesion contact turnover and stabilisation. However,
the mechanisms that dynamically control heterodimer-speciﬁc delivery
of integrins to the cell surface, in order to coordinate adhesion
dynamics, are poorly understood. We have identiﬁed the membrane-
intercalated proteoglycan syndecan-4, which serves a key role in the
development of osteoarthritis, as the regulatory control point that
coordinates integrin recycling.
